Product Categories
| Country: | China |
|---|---|
| Tel: | 0595-22008920 |
| Mobile: | 18120708884 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| (-)-(S)-B973B | C24H26F2N6O | 2244989-34-0 | Details |
| MA-0204 | C25H27F3N2O4 | 2095128-17-7 | Details |
| PF-06700841 | C18H21F2N7O | 1883299-62-4 | Details |
| TH34 | C15H16N2O2 | 2196203-96-8 | Details |
| IITZ-01 | C26H23FN8O | 1807988-47-1 | Details |
| 3-Methylimidazo[2,1-b]thiazole-2-carboxylic acid | C7H6N2O2S | 1017273-59-4 | Details |
| PF-06700841-TsOH | C25H29F2N7O4S | 2140301-96-6 | Details |
| ABX-1431 | C20H22F9N3O2 | 1446817-84-0 | Details |
| (1S)-6-methoxy-2,3-dihydro-1H-inden-1-amine hydrochloride | C10H14ClNO | 180915-62-2 | Details |
| WM-1119 | C18H13F2N3O3S | 2055397-28-7 | Details |
| 3-nitro-4H,5H,6H,7H-pyrazolo[1,5-a]pyrimidine | C6H8N4O2 | 148777-84-8 | Details |
| Lesinurad Impurity L | C15H12BrN3O2S | 1158970-49-0 | Details |
| ZK824859 | C22H20F2N2O4 | 2254001-81-3 | Details |
| Lesinurad Impurity 6 Di-Lithium Salt | Details |
| 4-(4-cyclopropylnaphthalen-1-yl)-1H-1,2,4-triazole-5(4H)-thione | C15H13N3S | 1533519-84-4 | Details |
| Lesinurad Impurity A | C17H14ClN3O2S | 1533519-98-0 | Details |
| Lesinurad Impurity 2 | C17H16N4O2S | 1158970-37-6 | Details |
| 2-propyl-4,7-dihydro-1,3-dioxepine | C8H14O2 | 4469-34-5 | Details |
| Safinamide | C17H19FN2O2 | 133865-89-1 | Details |
| methyl (2E)-3-(3,5-difluoro-4-formylphenyl)prop-2-enoate | C11H8F2O3 | 1639042-39-9 | Details |
| 3-Chloro-2-methyl-4-[2-(4-methyl-1-piperazinyl)ethoxy]phenylboronic Acid Pinacol Este | C20H32BClN2O3 | 1799612-11-5 | Details |
| (3R,4S,5S,6R)-2-(3-((5-(4-fluorophenyl)thiophen-2-yl)Methyl)-4-Methylphenyl)-6-(hydroxyMethyl)tetrahydro-2H-pyran-2,3,4,5-tetraol | C18H14BrFOS | 1818268-44-8 | Details |
| Canagliflozin-10 | C24H25FO5S | 2161394-94-9 | Details |
| EMA400 | C32H29NO5 | 152362-51-1 | Details |
| Cilofexor | C28H22Cl3N3O5 | 1418274-28-8 | Details |
| Cagliflozin impurity 9 | C19H15FO2S | 1956355-91-1 | Details |
| (3R,4S,5R,6R)-6-(acetoxyMethyl)-2-(3-((5-(4-fluorophenyl)thiophen-2-yl)Methyl)-4-Methylphenyl)-2-Methoxytetrahydro-2H-pyran-3,4,5-triyl | C33H35FO10S | 1222075-02-6 | Details |
| BLU9931 | C26H22Cl2N4O3 | 1538604-68-0 | Details |
| Canagliflozin α Isomer | C24H25FO5S | 1589590-87-3 | Details |
| (1-(2,2,2-Trifluoroethyl)-1H-pyrazol-5-yl)methanol | C6H7F3N2O | 1296225-26-7 | Details |
| 4,4-DIFLUOROCYCLOHEXANONE | C6H8F2O | 22515-18-0 | Details |
| 2-(5-broMo-2-Methylbenzyl)-5-phenylthiophene | C18H15BrS | 200545-69-1 | Details |
| Cagliar Net Impurity 10 | C24H27FO6S | 2268660-58-6 | Details |
| Canagliflozin | C24H25FO5S | 842133-18-0 | Details |
| BLU285 | C26H27FN10 | 1703793-34-3 | Details |
| AZD9496 | C25H25F3N2O2 | 1639042-08-2 | Details |
| 2-(1,2-dihydroxyethyl)-5-(3-((5-(4-fluorophenyl)thiophen-2-yl)Methyl)-4-Methylphenyl)tetrahydrofuran-3,4-diol | C24H25FO5S | 211533-80-5 | Details |
| Canagliflozin Impurity 14 | C24H25FO5S | 028977-37-8 | Details |
| MTX-211 | C20H14Cl2FN5O2S | 1952236-05-3 | Details |
| INCB | C20H21N3O5S | 1820889-23-3 | Details |
| 6-(3-Fluorophenyl)nicotinic acid | C12H8FNO2 | 582325-22-2 | Details |
| EMA401 | C32H29NO5 | 1316755-16-4 | Details |
| Methyl 2-bromo-4-fluorobenzo[d]thiazole-6-carboxylate | C9H5BrFNO2S | 924287-65-0 | Details |
| BAY-545 | C18H22F3N3O4S | 1699717-32-2 | Details |
| LJ570 | C27H22O3 | 2252488-69-8 | Details |
| PZ-2891 | C20H23N5O | 2170608-82-7 | Details |
| 2-(4-fluorophenyl)-5-(2-Methylbenzyl)thiophene | C18H15FS | 2005454-69-1 | Details |
| ML414(NGI-1) | C17H22N4O3S2 | 790702-57-7 | Details |
| D-Glucitol, 1,5-anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]Methyl]-4-Methylphenyl]-, tetraacetate, (1S)- (9CI) | C32H33FO9S | 866607-35-4 | Details |
| (5-broMo-2-Methylphenyl)(5-(4-fluorophenyl)thiophen-2-yl)Methanone | C18H12BrFOS | 1132832-75-7 | Details |
| SB225002 | C13H10BrN3O4 | 18298-32-4 | Details |
| GSK101 | C28H32Cl2N4O6S2 | 942206-85-1 | Details |
| Canagliflozin Impurity 10 | C24H25FO6S | 1672658-93-3 | Details |
| MALT1(inhibitor MI-2) | C19H17Cl3N4O3 | 1047953-91-2 | Details |
| RDEA 594 | C17H14BrN3O2S | 878672-00-5 | Details |
| brivaracetam | C11H20N2O2 | 357336-20-0 | Details |
| FR-179642 | C35H52N8O20S | 168110-44-9 | Details |
| Carbonic acid, 11,12-didehydro-5,6-dihydrodibenzo[a,e]cycloocten-5-yl 4-nitrophenyl ester | C23H15NO5 | 1027338-09-5 | Details |
| Dibenz[b,f]azocine-5(6H)-pentanoic acid, 11,12-didehydro-δ-oxo- | C20H17NO3 | 1207355-31-4 | Details |
| Olaparib | C24H23FN4O3 | 763113-22-0 | Details |
| Axitinib | C22H18N4OS | 319460-85-0 | Details |
| Empagliflozin | C23H27ClO7 | 864070-44-0 | Details |
| TICAGRELOR | C23H28F2N6O4S | 274693-27-5 | Details |
| Carbonic acid, bicyclo[6.1.0]non-4-yn-9-ylmethyl 4-nitrophenyl ester | C17H17NO5 | 1451095-01-4 | Details |
| (S)-1-((R)-1-(3,5-bis(trifluoroMethyl)phenyl)ethoxy)-2-phenylbut-3-en-2-aMine Maleic acid | C24H23F6NO5 | 1214741-14-6 | Details |
| UCB9608 | C20H26N8O2 | 1616413-96-7 | Details |
| FURO[3,4-B]FURAN-2(3H)-ONE, TETRAHYDRO-4-METHOXY-, (3AS,4S,6AR)- | C7H10O4 | 866594-60-7 | Details |
| tert-butyl formylcarbamate | C6H11NO3 | 913344-40-8 | Details |
| ： 3-(1,1-diMethylethyl)-7a-ethenyltetrahydro-1-hydroxy-(3R,7aR)-3H,5H-Pyrrolo[1,2-c]oxazol-5-one | C12H19NO3 | 1214741-21-5 | Details |
| BI-409306 | C16H17N5O2 | 1189767-28-9 | Details |
| 2-[3,5-bis(trifluoromethyl)phenyl]-N,2-dimethyl-N-[4-(2-methylphenyl)-6-(4-methylpiperazin-1-yl)pyridin-3-yl]propanamide | C30H32F6N4O | 290297-26-6 | Details |
| Rolapitant | C25H26F6N2O2 | 552292-08-7 | Details |
| NA | Details |
| ONO-8590580 | C21H21FN6 | 1802661-73-9 | Details |
| SCH23390 | C17H19Cl2NO | 87134-87-0 | Details |
| YC-1 | C19H16N2O2 | 170632-47-0 | Details |
| GNE-131 | C23H30N4O3S | 1629063-81-5 | Details |
| PLX51107 | C26H22N4O3 | 1627929-55-8 | Details |
| CYR-L0001522 | C18H15FN4O2 | 2286411-30-9 | Details |
| AB-423 | C17H17F3N2O3S | 1572510-80-5 | Details |
| CD437 | C27H26O3 | 125316-60-1 | Details |
| Tropifexor, LJN452 | C29H25F4N3O5S | 1383816-29-2 | Details |
| LAU159 | C17H12ClN3O2 | 2055050-87-6 | Details |
| RSL3 | C23H21ClN2O5 | 1219810-16-8 | Details |
| GM6001 | C20H28N4O4 | 142880-36-2 | Details |
| PF-06869206 | C15H14ClF3N4O2 | 2227425-05-8 | Details |
| N10-(TRIFLUOROACETYL)PTEROIC ACID | C16H11F3N6O4 | 37793-53-6 | Details |
| 22d | C22H19NO3 | 1417997-93-3 | Details |
| GLPG1837 | C16H20N4O3S | 1654725-02-6 | Details |
| ACSS | C20H18N4O2S2 | 508186-14-9 | Details |
| O-304 | C16H11Cl2N3O2S | 1261289-04-6 | Details |
| LMB-763 | C27H22ClN3O4 | 1773489-72-7 | Details |
| JNJ-632 | C18H19FN2O4S | 1572510-42-9 | Details |
| fulacimstat(BAY1142524) | C23H16F3N3O6 | 1488354-15-9 | Details |
| PRIMA-1MET 2-(Hydroxymethyl)-2-(methoxymethyl)quinuclidin-3-one 2-(Hydroxymethyl)-2-(methoxymethyl)-1-azabicyclo[2.2.2]octan-3-one APR-246 | C10H17NO3 | 5291-32-7 | Details |
| 3-[4-Hydroxy-3-[5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-3-(pentyloxy)-2-naphthalenyl]phenyl]-2-propenoicacid | C28H36O4 | 847239-17-2 | Details |
| Dibenzo[a,e]cycloocten-5-ol | C16H12O | 1027338-06-2 | Details |
| SPHINX31 | C27H24F3N5O2 | 1818389-84-2 | Details |
| Pimodivir | C20H19F2N5O2 | 1629869-44-8 | Details |
| Prima-1 | C9H15NO3 | 5608-24-2 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 | ||||